News

Categories

November 4, 2023

Zymeworks Presents Preclinical Data on Trispecific T Cell Engager Therapeutic Programs at the Society for Immunotherapy of Cancer (SITC) Conference

November 1, 2023

Zymeworks Announces Participation in Upcoming Investor Conferences

October 20, 2023

Zymeworks Showcases Updated Clinical Data for Zanidatamab at the 2023 ESMO Annual Congress

October 17, 2023

Zymeworks To Host Third Quarter 2023 Results Conference Call

October 16, 2023

Zymeworks Announces New Director Nominee

October 16, 2023

Jazz Pharmaceuticals to Showcase Growing Impact in Solid Tumor Oncology Research at ESMO 2023

September 27, 2023

Zymeworks to Present on Clinical and Preclinical Programs at Multiple Upcoming Medical Conferences

August 10, 2023

Zymeworks Provides Corporate Update and Reports Second Quarter 2023 Financial Results

August 1, 2023

Zymeworks Announces Participation in Upcoming Investor Conferences

July 19, 2023

Zymeworks To Host Second Quarter 2023 Results Conference Call

July 3, 2023

Zymeworks Announces Participation in Upcoming Investor Conference

June 29, 2023

Zymeworks Appoints New Director